Abstract
Pain is often associated with clinically relevant depression of behavior and mood, and relief of pain-related depression is a common goal of treatment in both human and veterinary medicine. In the development of pharmacological compounds to treat pain and related depression, preclinical studies may be used to evaluate the analgesic potential of new drugs. Such studies require reliable, accurate assays of pain-related behavioral depression in animals. Intracranial self-stimulation (ICSS) is a type of operant conditioning procedure that produces stable baseline behavioral response rates. The author reviews recent research on the use of ICSS to evaluate the expression and pharmacological modulation of pain-related behavioral depression in rats. Results suggest that assays of pain-depressed behavior using ICSS may serve as a useful new tool to improve the translation of preclinical findings to clinical results in analgesic drug development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain 6, 249–252 (1979).
Melzack, R. & Katz, J. in Textbook of Pain (eds. McMahon, L.R. & Koltzenburg, M.) 291–304 (Elsevier, London, UK, 2006).
Flecknell, P.A. Refinement of animal use—assessment and alleviation of pain and distress. Lab. Anim. 28, 222–231 (1994).
McGrath, P. in Textbook of Pain (eds. McMahon, L.R. & Koltzenburg, M.) 305–315 (Elsevier, London, UK, 2006).
National Research Council. Recognition and Alleviation of Pain in Laboratory Animals (National Academies Press, Washington, DC, 2009).
Negus, S.S. et al. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J. Pharmacol. Exp. Ther. 319, 507–514 (2006).
Negus, S.S., Bilsky, E.J., Pereira Do Carmo, G. & Stevenson, G.W. in Analgesia: Methods and Protocols (ed. Szallasi, A.) 79–91 (Humana, New York, 2010).
Blackburn-Munro, G. Pain-like behaviours in animals—how human are they? Trends Pharmacol. Sci. 25, 299–305 (2004).
Vierck, C.J., Hansson, P.T. & Yezierski, R.P. Clinical and pre-clinical pain assessment: are we measuring the same thing? Pain 135, 7–10 (2008).
Whiteside, G.T., Adedoyin, A. & Leventhal, L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54, 767–775 (2008).
Mogil, J.S. Animal models of pain: progress and challenges. Nat. Rev. Neurosci. 10, 283–294 (2009).
Mao, J. Current challenges in translational pain research. Trends Pharmacol. Sci. 33, 568–573 (2012).
Bair, M.J., Wu, J., Damush, T.M., Sutherland, J.M. & Kroenke, K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom. Med. 70, 890–897 (2008).
Goldenberg, D.L. Pain/Depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am. J. Med. 123, 675–682 (2010).
Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research (National Academies Press, Washington, DC, 2011).
Cleeland, C.S. & Ryan, K.M. Pain assessment: global use of the Brief Pain Inventory. Ann. Acad. Med. Singapore 23, 129–138 (1994).
Dworkin, R.H. et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113, 9–19 (2005).
National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (National Academies Press, Washington, DC, 2011).
Stevenson, G.W., Bilsky, E.J. & Negus, S.S. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J. Pain 7, 408–416 (2006).
Ferster, C.B. & Skinner, B.F. Schedules of Reinforcement (Prentice-Hall, Englewood Cliffs, NJ, 1957).
Kelleher, R.T. & Morse, W.H. Determinants of the specificity of behavioral effects of drugs. Ergeb. Physiol. 60, 1–56 (1968).
Skinner, B.F. The experimental analysis of behavior. American Scientist 45, 343–371 (1957).
Martin, T.J., Buechler, N.L., Kahn, W., Crews, J.C. & Eisenach, J.C. Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 101, 191–203 (2004).
Olds, J. & Milner, P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47, 419–427 (1954).
Stellar, J.R. & Stellar, E. The Neurobiology of Motivation and Reward (Springer, New York, 1985).
Carlezon, W.A. Jr. & Chartoff, E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2, 2987–2995 (2007).
Reid, L.D. in Methods of Assessing the Reinforcing Properties of Abused Drugs (ed. Bozarth, M.A.) 391–420 (Springer, Berlin, Germany, 1987).
Stellar, J.R. & Rice, M.B. in The Neuropharmacological Basis of Reward (ed. Liebman, J.M. & Cooper, S.J.) 14–65 (Oxford University Press, New York, 1989).
Vlachou, S. & Markou, A. in Animal Models of Drug Addiction (ed. Olmstead, M.C.) 3–56 (Humana, New York, 2011).
Pereira Do Carmo, G., Stevenson, G.W., Carlezon, W.A. & Negus, S.S. Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144, 170–177 (2009).
Negus, S.S., O'Connell, R., Morrissey, E., Cheng, K. & Rice, K.C. Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J. Pharmacol. Exp. Ther. 340, 501–509 (2012).
Hendershot, L.C. & Forsaith, J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J. Pharmacol. Exp. Ther. 125, 237–240 (1959).
Mogil, J.S., Wilson, S.G. & Wan, Y. in Methods in Pain Research (ed. Kruger, L.) 11–39 (CRC Press, Boca Raton, FL, 2001).
Stevenson, G.W. et al. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci. 85, 309–315 (2009).
Leitl, M. & Negus, S.S. Role of toll-like receptor 4 in pain-depressed behavior. Society for Neuroscience. New Orleans, LA, 13–17 October 2012.
Ewan, E.E. & Martin, T.J. Rewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioids. Anesthesiology 115, 1271–1280 (2011).
Langford, D.J. et al. Coding of facial expressions of pain in the laboratory mouse. Nat. Methods 7, 447–449 (2010).
Urban, R., Scherrer, G., Goulding, E.H., Tecott, L.H. & Basbaum, A.I. Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain 152, 990–1000 (2011).
Seminowicz, D.A. et al. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 47, 1007–1014 (2009).
Kwilasz, A.J. & Negus, S.S. Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats. J. Pharmacol. Exp. Ther. 343, 389–400 (2012).
Altarifi, A. & Negus, S.S. Effects of mu opioid receptor agonists on pain-stimulated and pain-depressed behaviors in rats. Society for Neuroscience. New Orleans, LA, 13–17 October 2012.
Negus, S.S. et al. Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats. J. Pain 13, 317–327 (2012).
Rosenberg, M., Carroll, F.I. & Negus, S.S. Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J. Pain 14, 246–259 (2013).
Wang, R.I., Johnson, R.P., Lee, J.C. & Waite, E.M. The oral analgesic efficacy of bicifadine hydrochloride in postoperative pain. J. Clin. Pharmacol. 22, 160–164 (1982).
Webb, S.S., Smith, G.M., Evans, W.O. & Webb, N.C. Toward the development of a potent, nonsedating, oral analgesic. Psychopharmacology (Berl.) 60, 25–28 (1978).
Villemure, C., Laferrière, A.C. & Bushnell, M.C. The ventral striatum is implicated in the analgesic effect of mood changes. Pain Res. Manag. 17, 69–74 (2012).
Wood, P.B. Role of central dopamine in pain and analgesia. Expert Rev. Neurother. 8, 781–797 (2008).
Yang, J.C., Clark, W.C., Dooley, J.C. & Mignogna, F.V. Effect of intranasal cocaine on experimental pain in man. Anesth. Analg. 61, 358–361 (1982).
Younger, J., Aron, A., Parke, S., Chatterjee, N. & Mackey, S. Viewing pictures of a romantic partner reduces experimental pain: involvement of neural reward systems. PLoS One 5, e13309 (2010).
Ling, W., Mooney, L. & Hillhouse, M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 30, 300–305 (2011).
Negus, S.S., Gatch, M.B., Mello, N.K., Zhang, X. & Rice, K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286, 362–375 (1998).
Nicholson, K.L. et al. Preclinical evaluation of the abuse potential of the analgesic bicifadine. J. Pharmacol. Exp. Ther. 330, 236–248 (2009).
Negus, S.S., Morrissey, E.M., Rosenberg, M., Cheng, K. & Rice, K.C. Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl.) 210, 149–159 (2010).
Roughan, J.V., Wright-Williams, S.L. & Flecknell, P.A. Automated analysis of postoperative behaviour: assessment of HomeCageScan as a novel method to rapidly identify pain and analgesic effects in mice. Lab. Anim. 43, 17–26 (2009).
Cobos, E.J. et al. Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain 153, 876–884 (2012).
Matson, D.J. Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J. Pharmacol. Exp. Ther. 320, 194–201 (2007).
Pardo, E.G. & Rodríguez, R. Reversal by acetylsalicylic acid of pain induced functional impairment. Life Sciences 5, 775–781 (1966).
Negus, S.S., Leitl, M. & Banks, M.L. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous kappa opioids. American College of Neuropsychopharmacology 51st Annual Meeting. Hollywood, FL, 2–6 December 2012.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Negus, S. Expression and treatment of pain-related behavioral depression. Lab Anim 42, 292–300 (2013). https://doi.org/10.1038/laban.255
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/laban.255
This article is cited by
-
Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats
Psychopharmacology (2022)
-
Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats
Psychopharmacology (2021)
-
Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats
Psychopharmacology (2020)
-
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats
Psychopharmacology (2018)
-
Sustained Pain-Related Depression of Behavior: Effects of Intraplantar Formalin and Complete Freund's Adjuvant on Intracranial Self-Stimulation (ICSS) and Endogenous kappa Opioid Biomarkers in Rats
Molecular Pain (2014)